Screener
ImmunityBio, Inc. IBRX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $75.67M-45.0% | $205.19M+238% | $88.33M-38.4% | $60.24M-46.2% | $137.66M+5.8% | ||
| $281.7M+1,661% | $175.69M+18,771% | $154.48M+2,321% | $197.57M+974% | $16M-81.8% | ||
| $53.47M+142% | $43.27M+154% | $42.57M+1,704% | $32.02M+667% | $22.13M+2,042% | ||
| $16.42M+147% | $18.86M+123% | $13.51M— | $6.7M+242% | $6.64M+267% | ||
| $438.98M+111% | $452.95M+315% | $314.88M+70.6% | $329.5M+102% | $208.13M-14.3% | ||
| $114.22M-14.1% | $112.79M-16.6% | $114.26M-16.7% | $129.6M-7.0% | $133M-6.3% | ||
| $11.84M+1,201% | $910K0.0% | $910K0.0% | $910K0.0% | $910K— | ||
| $628.5M+56.3% | $646.64M+113% | $501.9M+31.1% | $518.99M+42.4% | $402.08M-9.5% | ||
| $55K+12.2% | $53K— | $52K— | $50K— | $49K+123% | ||
| $76.73M+51.5% | $67.95M+38.1% | $61.75M+12.4% | $57.13M-6.3% | $50.64M-18.5% | ||
| $415.09M+35.2% | $404.3M+36.5% | $324.62M+14.1% | $316.15M+15.5% | $307.05M+16.6% | ||
| $1.15B+18.4% | $1.52B+69.5% | $581.25M-33.3% | $1.04B-6.0% | $971.9M-14.9% | ||
| 1.7B+22.2% | 1.7B+22.2% | 1.7B+1,941,076% | 1.4B0.0% | 1.4B0.0% | ||
| -$4.59B-27.6% | -$4.36B-24.4% | -$3.73B-10.4% | -$3.66B-10.5% | -$3.6B-11.4% | ||
| -$1.05B-83.4% | -$870.01M-47.1% | -$500.47M-2.3% | -$524.32M+29.6% | -$570.75M+18.3% | ||
| $628.5M+56.3% | $646.64M+113% | $501.9M+31.1% | $518.99M+42.4% | $402.08M-9.5% |
FAQ
- What are ImmunityBio, Inc.'s total assets?
- ImmunityBio, Inc. (IBRX) holds $628.5M in total assets, up 56.3% year over year.
- How much debt does ImmunityBio, Inc. have?
- ImmunityBio, Inc. carries $454.1M in total debt against -$1.0B of shareholders' equity, a debt-to-equity ratio of 0.11.
- How much cash does ImmunityBio, Inc. have?
- ImmunityBio, Inc. holds $75.7M in cash and equivalents.
- Can ImmunityBio, Inc. cover its short-term obligations?
- Its current ratio is 5.72 — current assets exceed current liabilities.
- Where does ImmunityBio, Inc.'s balance sheet data come from?
- Every line is extracted from ImmunityBio, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
